Survival outcomes and prognostic nutritional index in very elderly small-cell lung cancer patients: importance of active treatment and nutritional support

References

• Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24(28):4539–4544. doi: 10.1200/JCO.2005.04.4859.
   PubMed Web of Science ®Google Scholar
• Horn L, Mansfield AS, Szczęsna A, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med. 2018;379(23):2220–2229. doi: 10.1056/NEJMoa1809064.
   PubMed Web of Science ®Google Scholar
• Rudin CM, Brambilla E, Faivre-Finn C, et al. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3. doi: 10.1038/s41572-020-00235-0.
   PubMed Web of Science ®Google Scholar
• Mastronuzzi T, Grattagliano I. Nutrition as a health determinant in elderly patients. Curr Med Chem. 2019;26(19):3652–3661. doi: 10.2174/0929867324666170523125806.
   PubMed Web of Science ®Google Scholar
• Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–1196. doi: 10.1016/j.clnu.2017.06.017.
   PubMed Web of Science ®Google Scholar
• Barreira JV. The role of nutrition in cancer patients. Nutr Cancer. 2021;73(11–12):2849–2850. doi: 10.1080/01635581.2020.1839519.
   PubMed Web of Science ®Google Scholar
• Wang D, Hu X, Xiao L, et al. Prognostic nutritional index and systemic immune-inflammation index predict the prognosis of patients with HCC. J Gastrointest Surg. 2021;25(2):421–427. doi: 10.1007/s11605-019-04492-7.
   PubMed Web of Science ®Google Scholar
• Ding P, Guo H, Sun C, et al. Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study. BMC Gastroenterol. 2022;22(1):121. doi: 10.1186/s12876-022-02199-9.
   PubMed Web of Science ®Google Scholar
• Sozel H, Beypinar I, Sezgin Goksu S. Prognostic impact of prognostic nutritional index and neutrophil/lymphocyte ratio in patients with small-cell lung cancer. EJMI. 2021;5(2):207–212. doi: 10.14744/ejmi.2021.54277.
   Google Scholar
• Lichtman SM. Therapy insight: therapeutic challenges in the treatment of elderly cancer patients. Nat Clin Pract Oncol. 2006;3(2):86–93. doi: 10.1038/ncponc0420.
   PubMedGoogle Scholar
• Okamoto H, Watanabe K, Kunikane H, et al. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702. Br J Cancer. 2007;97(2):162–169. doi: 10.1038/sj.bjc.6603810.
   PubMed Web of Science ®Google Scholar
• Yuen AR, Zou G, Turrisi AT, et al. Similar outcome of elderly patients in intergroup trial 0096: cisplatin, etoposide, and thoracic radiotherapy administered once or twice daily in limited stage small cell lung carcinoma. Cancer. 2000;89(9):1953–1960. doi: 10.1002/1097-0142(20001101)89:9<1953::AID-CNCR11>3.0.CO;2-6.
   PubMed Web of Science ®Google Scholar
• Liu S, Guo H, Kong L, et al. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute. Int J Clin Exp Pathol. 2015;8(9):11033–11041.
   PubMed Web of Science ®Google Scholar
• Jett JR, Schild SE, Kesler KA, et al. Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e400S–e419S. doi: 10.1378/chest.12-2363.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327(23):1618–1624. doi: 10.1056/NEJM199212033272302.
   PubMed Web of Science ®Google Scholar
• Slotman BJ, van Tinteren H, Praag JO, et al. Radiotherapy for extensive stage small-cell lung cancer - Authors’ reply. Lancet. 2015;385(9975):1292–1293. doi: 10.1016/S0140-6736(15)60679-1.
   PubMed Web of Science ®Google Scholar
• An CC, Jing W, Zhang Y, et al. Thoracic radiation therapy could give survival benefit to elderly patients with extensive-stage small-cell lung cancer. Future Oncol. 2017;13(13):1149–1158. doi: 10.2217/fon-2016-0467.
   PubMed Web of Science ®Google Scholar
• Corso CD, Rutter CE, Park HS, et al. Role of chemoradiotherapy in elderly patients with limited-stage small-cell lung cancer. J Clin Oncol. 2015;33(36):4240–4246. doi: 10.1200/JCO.2015.62.4270.
   PubMed Web of Science ®Google Scholar
• Sundriyal D, Kumar P, Kumar U, et al. Chemotherapy in geriatric patients with poor performance status small cell lung cancer: series from a tertiary care center. Aging Med. 2022;5(2):138–141. doi: 10.1002/agm2.12205.
   PubMedGoogle Scholar
• Sagman U, Maki E, Evans WK, et al. Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol. 1991;9(9):1639–1649. doi: 10.1200/JCO.1991.9.9.1639.
   PubMed Web of Science ®Google Scholar
• He X, Zhou T, Yang Y, et al. Advanced lung cancer inflammation index, a new prognostic score, predicts outcome in patients with small-cell lung cancer. Clin Lung Cancer. 2015;16(6):e165–71–e171. doi: 10.1016/j.cllc.2015.03.005.
   PubMed Web of Science ®Google Scholar
• Hong S, Zhou T, Fang W, et al. The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients. Tumour Biol. 2015;36(5):3389–3397. doi: 10.1007/s13277-014-2973-y.
   PubMedGoogle Scholar
• Zhou T, Zhan J, Hong S, et al. Ratio of C reactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer. Sci Rep. 2015;5(1):10481. doi: 10.1038/srep10481.
   PubMedGoogle Scholar
• Yang Y, Gao P, Song Y, et al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a metaanalysis. Eur J Surg Oncol. 2016;42(8):1176–1182. doi: 10.1016/j.ejso.2016.05.029.
   PubMed Web of Science ®Google Scholar